October 15, 2019
During oral arguments Friday, a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit seemed likely to uphold a lower court ruling against Medicaid work requirements in Arkansas and Kentucky.
October 14, 2019
Federal judges in three states on Friday temporarily blocked a final rule issued by the Trump administration that would allow federal officials to consider whether immigrants are receiving or are likely to receive Medicaid or other public benefits when reviewing their residency applications.
October 11, 2019
The Little Sisters of the Poor, an order of nuns, last week asked the Supreme Court to review a ruling by a federal appeals court that blocks the Trump administration's exemptions to the Affordable Care Act's contraceptive coverage rules.
American Health Line rounds up the latest health care news in the states.
October 10, 2019
A Philadelphia jury on Tuesday ordered New Jersey-based Johnson & Johnson (J&J) to pay $8 billion in punitive damages to a Maryland man who claimed J&J failed to properly warn patients and providers that its antipsychotic drug Risperdal could spur breast growth in boys.
October 9, 2019
The Supreme Court on Monday denied drugmaker Acorda Therapeutics' request to hear a case regarding patents for the company's multiple sclerosis treatment Ampyra, meaning generic versions of the drug can remain on the market.
October 8, 2019
The Supreme Court on Friday announced that it will hear a case challenging a Louisiana law that would impose new requirements on abortion providers, marking the first major abortion-related case the high court will hear since President Trump's conservative-leaning justice nominees were confirmed.
October 7, 2019
The Federal Trade Commission last month sent warning letters to seven law firms and marketing companies, warning that their ads seeking patients for personal injury lawsuits against drugmakers could violate federal law and cause patients to avoid taking their medications.
October 4, 2019
A federal judge this week ruled that a Philadelphia nonprofit can open a medically supervised injection site under U.S. law, an unprecedented ruling that could open the door for other cities to pursue so-called "safe-injection" sites to combat the opioid epidemic.
October 2, 2019
Johnson & Johnson on Tuesday announced that it has reached an agreement with two Ohio counties to settle claims, with no admission of liability, that the drugmaker contributed to the U.S. opioid epidemic.
Advisory Board. All rights reserved.